UCB (UCBJY) Short Interest Ratio & Short Volume $81.73 -6.58 (-7.45%) As of 04/4/2025 03:55 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartDividendFinancialsHeadlinesSEC FilingsShort InterestBuy This Stock UCB Short Interest DataUCB (UCBJY) has a short interest of 13,500 shares, representing 0.00% of the float (the number of shares available for trading by the public). This marks a -2.88% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 38,795 shares to cover all short positions.Current Short Interest13,500 sharesPrevious Short Interest13,900 sharesChange Vs. Previous Month-2.88%Dollar Volume Sold Short$1.33 millionShort Interest Ratio0.1 Days to CoverLast Record DateMarch 15, 2025Outstanding Shares378,040,000 sharesShort Percent of Float0.00%Today's Trading Volume39,804 sharesAverage Trading Volume38,795 sharesToday's Volume Vs. Average103% Short Selling UCB? Sign up to receive the latest short interest report for UCB and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartUCBJY Short Interest Over TimeUCBJY Days to Cover Over TimeUCBJY Percentage of Float Shorted Over Time Remove Ads UCB Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/202513,500 shares $1.33 million -2.9%0.0%0.1 $98.26 2/28/202513,900 shares $1.32 million +363.3%0.0%0.2 $95.06 2/15/20253,000 shares $282,930.00 +3.5%0.0%0 $94.31 1/31/20252,900 shares $281,822.00 +2,800.0%N/A0 $97.18 1/15/2025100 shares $9,805.80 -97.9%N/A0 $98.06 12/31/20244,700 shares $464,595.00 +2,250.0%N/A0.3 $98.85 12/15/2024200 shares $18,942.00 -80.0%N/A0 $94.71 11/30/20241,000 shares $98,015.00 +25.0%N/A0 $98.02 11/15/2024800 shares $70,324.00 -73.3%N/A0 $87.91 10/31/20243,000 shares $287,910.00 -95.9%N/A0.1 $95.97 Get the Latest News and Ratings for UCBJY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for UCB and its competitors with MarketBeat's FREE daily newsletter. 10/15/202473,100 shares $6.88 million +10,342.9%N/A1.4 $94.15 9/30/2024700 shares $63,140.00 +133.3%N/A0.1 $90.20 9/15/2024300 shares $27,027.00 +200.0%N/A0 $90.09 8/31/2024100 shares $9,072.00 No ChangeN/A0 $90.72 8/15/2024100 shares $8,445.40 -99.1%N/A0 $84.45 7/31/202411,100 shares $931,456.50 +164.3%N/A0.1 $83.92 7/15/20244,200 shares $328,986.00 +31.3%N/A0.3 $78.33 6/30/20243,200 shares $237,216.00 -87.5%N/A0.1 $74.13 6/15/202425,500 shares $1.88 million +65.6%N/A1 $73.75 5/31/202415,400 shares $1.07 million +152.5%N/A0.1 $69.68 5/15/20246,100 shares $406,138.00 +38.6%N/A0.1 $66.58 4/30/20244,400 shares $291,412.00 +69.2%N/A0.1 $66.23 4/15/20242,600 shares $163,800.00 +1,200.0%N/A0.1 $63.00 3/31/2024200 shares $12,323.00 -71.4%N/A0 $61.62 3/15/2024700 shares $39,739.00 -90.0%N/A0 $56.77 2/29/20247,000 shares $402,920.00 +233.3%N/A0.3 $57.56 2/15/20242,100 shares $107,100.00 -60.4%N/A0.1 $51.00 1/15/20244,700 shares $216,834.50 -58.4%N/A0.2 $46.14 12/31/202311,300 shares $492,680.00 -27.1%N/A0.5 $43.60 12/15/202315,500 shares $611,668.75 +307.9%N/A0.6 $39.46 11/30/20233,800 shares $139,802.00 +1,800.0%N/A0.1 $36.79 11/15/2023200 shares $7,354.00 +100.0%N/A0 $36.77 10/31/2023100 shares $3,658.00 -66.7%N/A0 $36.58 10/15/2023300 shares $12,654.00 No ChangeN/A0 $42.18 9/15/20233,300 shares $147,708.00 +50.0%N/A0.1 $44.76 8/31/20232,200 shares $98,692.00 -66.2%N/A0.2 $44.86 8/15/20236,500 shares $290,940.00 +282.4%N/A0.5 $44.76 7/31/20231,700 shares $75,105.49 +21.4%N/A0.1 $44.18 7/15/20231,400 shares $62,244.00 -62.2%N/A0.1 $44.46 6/30/20233,700 shares $164,650.00 -9.8%N/A0.3 $44.50[Action Required] Claim Your FREE IRS Loophole Guide (Ad)This shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the biggest "dollar reset" since 1971.So claim your FREE copy of this 2025 Gold Guide to learn more. 6/15/20234,100 shares $190,773.00 +1,266.7%N/A0.3 $46.53 5/31/2023300 shares $13,104.00 +200.0%N/A0 $43.68 5/15/2023100 shares $4,695.00 -90.9%N/A0 $46.95 4/30/20231,100 shares $52,118.00 -8.3%N/A0.1 $47.38 4/15/20231,200 shares $57,804.00 -62.5%N/A0.1 $48.17 3/31/20233,200 shares $143,104.00 +77.8%N/A0.2 $44.72 3/15/20231,800 shares $75,492.00 -50.0%N/A0.1 $41.94 2/28/20233,600 shares $154,440.00 +33.3%N/A0.2 $42.90 2/15/20232,700 shares $112,401.00 +58.8%N/A0.1 $41.63 1/31/20231,700 shares $69,589.50 -84.0%N/A0.1 $40.94 1/15/202310,600 shares $457,973.00 +404.8%N/A0.4 $43.21 12/30/20222,100 shares $82,530.00 +950.0%N/A0.1 $39.30 12/15/2022200 shares $7,822.00 -96.2%N/A0 $39.11 11/30/20225,300 shares $212,689.00 +140.9%N/A0.2 $40.13 11/15/20222,200 shares $84,612.00 -40.5%N/A0 $38.46 10/31/20223,700 shares $139,157.00 -81.1%N/A0.1 $37.61 10/15/202219,600 shares $707,952.00 +106.3%N/A0.2 $36.12 9/30/20229,500 shares $328,985.00 -80.0%N/A0.1 $34.63 9/15/202247,500 shares $1.63 million +283.1%N/A0.3 $34.36 8/31/202212,400 shares $435,116.00 +3,000.0%N/A0.1 $35.09 8/15/2022400 shares $14,916.00 -96.0%N/A0 $37.29 7/31/202210,100 shares $393,900.00 -69.7%N/A0.2 $39.00 7/15/202233,300 shares $1.40 million +35.9%N/A0.5 $42.03 6/30/202224,500 shares $1.03 million +1,066.7%N/A0.3 $42.23 6/15/20222,100 shares $87,685.50 +2,000.0%N/A0 $41.76 5/31/2022100 shares $4,417.00 No ChangeN/A0 $44.17 5/15/2022100 shares $4,571.00 -95.5%N/A0 $45.71 4/30/20222,200 shares $124,476.00 -68.1%N/A0.1 $56.58 4/15/20226,900 shares $433,665.00 +176.0%N/A0.2 $62.85 3/31/20222,500 shares $150,350.00 +56.3%N/A0.1 $60.14 3/15/20221,600 shares $88,272.00 -70.9%N/A0 $55.17 2/28/20225,500 shares $297,935.00 +1,275.0%N/A0.1 $54.17 2/15/2022400 shares $19,540.00 -66.7%N/A0 $48.85 1/31/20221,200 shares $59,436.00 -61.3%N/A0 $49.53 1/15/20223,100 shares $156,612.00 +675.0%N/A0.1 $50.52 12/31/2021400 shares $22,744.00 -50.0%N/A0 $56.86 12/15/2021800 shares $43,536.00 -68.0%N/A0 $54.42 11/30/20212,500 shares $136,750.00 -45.7%N/A0.1 $54.70 11/15/20214,600 shares $274,804.00 +119.1%N/A0.3 $59.74 10/29/20212,100 shares $126,042.00 +61.5%N/A0.2 $60.02 10/15/20211,300 shares $73,755.50 -92.6%N/A0.1 $56.74 9/30/202117,500 shares $988,575.00 +153.6%N/A0.2 $56.49 9/15/20216,900 shares $367,080.00 +6.2%N/A0.4 $53.20 8/31/20216,500 shares $371,215.00 +103.1%N/A0.4 $57.11 8/13/20213,200 shares $185,248.00 +18.5%N/A0.1 $57.89 7/30/20212,700 shares $148,797.00 -65.8%N/A0.1 $55.11 7/15/20217,900 shares $414,276.00 -46.6%N/A0.4 $52.44 6/30/202114,800 shares $773,670.00 +228.9%N/A0.3 $52.28 6/15/20214,500 shares $229,680.00 +150.0%N/A0.2 $51.04 5/28/20211,800 shares $85,194.00 +12.5%N/A0.1 $47.33[Action Required] Claim Your FREE IRS Loophole Guide (Ad)This shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the biggest "dollar reset" since 1971.So claim your FREE copy of this 2025 Gold Guide to learn more. 5/14/20211,600 shares $74,464.00 -44.8%N/A0 $46.54 4/30/20212,900 shares $135,227.00 -12.1%N/A0 $46.63 4/15/20213,300 shares $157,492.50 +32.0%N/A0.1 $47.73 3/31/20212,500 shares $119,387.50 -81.2%N/A0.1 $47.76 3/15/202113,300 shares $633,346.00 +43.0%N/A0.4 $47.62 2/26/20219,300 shares $485,367.00 +29.2%N/A0.4 $52.19 2/12/20217,200 shares $382,608.00 +9.1%N/A0.3 $53.14 1/29/20216,600 shares $348,348.00 -68.3%N/A0.3 $52.78 1/15/2021300 shares $16,117.50 -91.4%N/A0 $53.73 12/31/20205,800 shares $305,805.00 +1,833.3%N/A0.2 $52.73 12/15/2020300 shares $15,799.20 -91.4%N/A0 $52.66 11/30/20203,500 shares $188,195.00 -12.5%N/A0.2 $53.77 10/30/202013,000 shares $663,390.00 +132.1%N/A0.6 $51.03 10/15/20205,600 shares $311,976.00 +409.1%N/A0.3 $55.71 9/30/20201,100 shares $62,821.00 -73.2%N/A0.1 $57.11 9/15/20204,100 shares $235,873.00 +720.0%N/A0.4 $57.53 8/31/2020500 shares $29,980.00 -73.7%N/A0.1 $59.96 8/14/20201,900 shares $114,926.25 -98.7%N/A0.2 $60.49 7/31/2020143,000 shares $9.24 million +751.2%N/A2.5 $64.60 7/15/202016,800 shares $1.08 million +8,300.0%N/A0.3 $64.01 6/30/2020200 shares $11,646.00 -50.0%N/A0.5 $58.23 6/15/2020400 shares $23,256.00 -33.3%N/A0.2 $58.14 5/29/2020600 shares $29,923.50 -33.3%N/A0.5 $49.87 5/15/2020900 shares $41,454.00 +800.0%N/A0.7 $46.06 4/30/2020100 shares $4,621.50 -50.0%N/A0.1 $46.22 4/15/2020200 shares $8,954.00 +100.0%N/A0.7 $44.77 UCBJY Short Interest - Frequently Asked Questions What is UCB's current short interest? Short interest is the volume of UCB shares that have been sold short but have not yet been closed out or covered. As of March 15th, investors have sold 13,500 shares of UCBJY short. 0.00% of UCB's shares are currently sold short. Learn More on UCB's current short interest. What is a good short interest percentage for UCB? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.00% of UCB's floating shares are currently sold short. Is UCB's short interest increasing or decreasing? UCB saw a decrease in short interest in March. As of March 15th, there was short interest totaling 13,500 shares, a decrease of 2.9% from the previous total of 13,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does UCB's short interest compare to its competitors? 0.00% of UCB's shares are currently sold short. Here is how the short interest of companies compare to UCB: Vertex Pharmaceuticals Incorporated (2.25%), Bristol-Myers Squibb (1.82%), GSK plc (0.86%), CSL Limited (0.00%), Zoetis Inc. (1.59%), Regeneron Pharmaceuticals, Inc. (3.21%), Daiichi Sankyo Company, Limited (0.00%), Takeda Pharmaceutical Company Limited (0.14%), Alnylam Pharmaceuticals, Inc. (1.99%), UCB SA (0.25%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), MicroStrategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks. What does it mean to sell short UCB stock? Short selling UCBJY is an investing strategy that aims to generate trading profit from UCB as its price is falling. UCBJY shares are trading down $6.58 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against UCB? A short squeeze for UCB occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of UCBJY, which in turn drives the price of the stock up even further. How often is UCB's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including UCBJY, twice per month. The most recent reporting period available is March, 15 2025. More Short Interest Resources from MarketBeat Related Companies Vertex Pharmaceuticals Short Squeeze Bristol-Myers Squibb Short Squeeze GSK Short Squeeze CSL Short Squeeze Zoetis Short Squeeze Regeneron Pharmaceuticals Short Squeeze Daiichi Sankyo Short Squeeze Takeda Pharmaceutical Short Squeeze Alnylam Pharmaceuticals Short Squeeze UCB Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:UCBJY) was last updated on 4/5/2025 by MarketBeat.com Staff From Our PartnersAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredBrace Yourself for Jeff Bezos’ “Amazon Helios”Jeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | SponsoredIt’s Time to Buy Elon’s “ChatGPT Killer”Elon Musk’s new AI model is blowing everyone’s mind. It has been called “a game-changer in AI innovation”.....Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding UCB SA Please log in to your account or sign up in order to add this asset to your watchlist. Share UCB With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.